Selected research
Industry Research
Weight Reduction Medicine Industry Research Report 2026
Market perspective
The global Weight Reduction Medicine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Weight Reduction Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Weight Reduction Medicine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Weight Reduction Medicine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Weight Reduction Medicine include Teva, Sandoz(Novartis), Roche, GSK group, Zein Pharmaceutical, Taj Pharmaceuticals Ltd, STADA-VN J.V.Co., Ltd, National Company For Pharmaceutical Industry and Lunan Pharmaceutical Group Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Weight Reduction Medicine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Weight Reduction Medicine Market by Company
Teva
Sandoz(Novartis)
Roche
GSK group
Zein Pharmaceutical
Taj Pharmaceuticals Ltd
STADA-VN J.V.Co., Ltd
National Company For Pharmaceutical Industry
Lunan Pharmaceutical Group Corporation
Kabir Life Sciences & Research
Hisun
Hexal AG
Dm Pharma
China Zhongshan Pharm
Weight Reduction Medicine Segment by Type
Liauid
Tablets
Weight Reduction Medicine Segment by Application
Weight-reducing Aid
Other
Weight Reduction Medicine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Weight Reduction Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Weight Reduction Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Weight Reduction Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Weight Reduction Medicine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Weight Reduction Medicine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Weight Reduction Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Liauid
- Tablets
Applications
- Weight-reducing Aid
- Other
Companies covered
- Teva
- Sandoz(Novartis)
- Roche
- GSK group
- Zein Pharmaceutical
- Taj Pharmaceuticals Ltd
- STADA-VN J.V.Co., Ltd
- National Company For Pharmaceutical Industry
- Lunan Pharmaceutical Group Corporation
- Kabir Life Sciences & Research
- Hisun
- Hexal AG
- Dm Pharma
- China Zhongshan Pharm
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Weight Reduction Medicine Market Size (2021-2032)
- 2.2.2 Global Weight Reduction Medicine Sales (2021-2032)
- 2.2.3 Global Weight Reduction Medicine Market Average Price (2021-2032)
- 2.3 Weight Reduction Medicine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Liauid
- 2.3.3 Tablets
- 2.4 Weight Reduction Medicine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Weight-reducing Aid
- 2.4.3 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Weight Reduction Medicine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Weight Reduction Medicine Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Weight Reduction Medicine Revenue of Manufacturers (2021-2026)
- 3.4 Global Weight Reduction Medicine Average Price by Manufacturers (2021-2026)
- 3.5 Global Weight Reduction Medicine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Weight Reduction Medicine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Weight Reduction Medicine, Product Type & Application
- 3.8 Global Manufacturers of Weight Reduction Medicine, Established Date
- 3.9 Global Weight Reduction Medicine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva
- 4.1.1 Teva Company Information
- 4.1.2 Teva Business Overview
- 4.1.3 Teva Weight Reduction Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Weight Reduction Medicine Product Portfolio
- 4.1.5 Teva Recent Developments
- 4.2 Sandoz(Novartis)
- 4.2.1 Sandoz(Novartis) Company Information
- 4.2.2 Sandoz(Novartis) Business Overview
- 4.2.3 Sandoz(Novartis) Weight Reduction Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sandoz(Novartis) Weight Reduction Medicine Product Portfolio
- 4.2.5 Sandoz(Novartis) Recent Developments
- 4.3 Roche
- 4.3.1 Roche Company Information
- 4.3.2 Roche Business Overview
- 4.3.3 Roche Weight Reduction Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Roche Weight Reduction Medicine Product Portfolio
- 4.3.5 Roche Recent Developments
- 4.4 GSK group
- 4.4.1 GSK group Company Information
- 4.4.2 GSK group Business Overview
- 4.4.3 GSK group Weight Reduction Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 GSK group Weight Reduction Medicine Product Portfolio
- 4.4.5 GSK group Recent Developments
- 4.5 Zein Pharmaceutical
- 4.5.1 Zein Pharmaceutical Company Information
- 4.5.2 Zein Pharmaceutical Business Overview
- 4.5.3 Zein Pharmaceutical Weight Reduction Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Zein Pharmaceutical Weight Reduction Medicine Product Portfolio
- 4.5.5 Zein Pharmaceutical Recent Developments
- 4.6 Taj Pharmaceuticals Ltd
- 4.6.1 Taj Pharmaceuticals Ltd Company Information
- 4.6.2 Taj Pharmaceuticals Ltd Business Overview
- 4.6.3 Taj Pharmaceuticals Ltd Weight Reduction Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Taj Pharmaceuticals Ltd Weight Reduction Medicine Product Portfolio
- 4.6.5 Taj Pharmaceuticals Ltd Recent Developments
- 4.7 STADA-VN J.V.Co., Ltd
- 4.7.1 STADA-VN J.V.Co., Ltd Company Information
- 4.7.2 STADA-VN J.V.Co., Ltd Business Overview
- 4.7.3 STADA-VN J.V.Co., Ltd Weight Reduction Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 STADA-VN J.V.Co., Ltd Weight Reduction Medicine Product Portfolio
- 4.7.5 STADA-VN J.V.Co., Ltd Recent Developments
- 4.8 National Company For Pharmaceutical Industry
- 4.8.1 National Company For Pharmaceutical Industry Company Information
- 4.8.2 National Company For Pharmaceutical Industry Business Overview
- 4.8.3 National Company For Pharmaceutical Industry Weight Reduction Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 National Company For Pharmaceutical Industry Weight Reduction Medicine Product Portfolio
- 4.8.5 National Company For Pharmaceutical Industry Recent Developments
- 4.9 Lunan Pharmaceutical Group Corporation
- 4.9.1 Lunan Pharmaceutical Group Corporation Company Information
- 4.9.2 Lunan Pharmaceutical Group Corporation Business Overview
- 4.9.3 Lunan Pharmaceutical Group Corporation Weight Reduction Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Lunan Pharmaceutical Group Corporation Weight Reduction Medicine Product Portfolio
- 4.9.5 Lunan Pharmaceutical Group Corporation Recent Developments
- 4.10 Kabir Life Sciences & Research
- 4.10.1 Kabir Life Sciences & Research Company Information
- 4.10.2 Kabir Life Sciences & Research Business Overview
- 4.10.3 Kabir Life Sciences & Research Weight Reduction Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Kabir Life Sciences & Research Weight Reduction Medicine Product Portfolio
- 4.10.5 Kabir Life Sciences & Research Recent Developments
- 4.11 Hisun
- 4.11.1 Hisun Company Information
- 4.11.2 Hisun Business Overview
- 4.11.3 Hisun Weight Reduction Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Hisun Weight Reduction Medicine Product Portfolio
- 4.11.5 Hisun Recent Developments
- 4.12 Hexal AG
- 4.12.1 Hexal AG Company Information
- 4.12.2 Hexal AG Business Overview
- 4.12.3 Hexal AG Weight Reduction Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Hexal AG Weight Reduction Medicine Product Portfolio
- 4.12.5 Hexal AG Recent Developments
- 4.13 Dm Pharma
- 4.13.1 Dm Pharma Company Information
- 4.13.2 Dm Pharma Business Overview
- 4.13.3 Dm Pharma Weight Reduction Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Dm Pharma Weight Reduction Medicine Product Portfolio
- 4.13.5 Dm Pharma Recent Developments
- 4.14 China Zhongshan Pharm
- 4.14.1 China Zhongshan Pharm Company Information
- 4.14.2 China Zhongshan Pharm Business Overview
- 4.14.3 China Zhongshan Pharm Weight Reduction Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 China Zhongshan Pharm Weight Reduction Medicine Product Portfolio
- 4.14.5 China Zhongshan Pharm Recent Developments
5 Global Weight Reduction Medicine Market Scenario by Region
- 5.1 Global Weight Reduction Medicine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Weight Reduction Medicine Sales by Region: 2021-2032
- 5.2.1 Global Weight Reduction Medicine Sales by Region: 2021-2026
- 5.2.2 Global Weight Reduction Medicine Sales by Region: 2027-2032
- 5.3 Global Weight Reduction Medicine Revenue by Region: 2021-2032
- 5.3.1 Global Weight Reduction Medicine Revenue by Region: 2021-2026
- 5.3.2 Global Weight Reduction Medicine Revenue by Region: 2027-2032
- 5.4 North America Weight Reduction Medicine Market Facts & Figures by Country
- 5.4.1 North America Weight Reduction Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Weight Reduction Medicine Sales by Country (2021-2032)
- 5.4.3 North America Weight Reduction Medicine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Weight Reduction Medicine Market Facts & Figures by Country
- 5.5.1 Europe Weight Reduction Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Weight Reduction Medicine Sales by Country (2021-2032)
- 5.5.3 Europe Weight Reduction Medicine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Weight Reduction Medicine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Weight Reduction Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Weight Reduction Medicine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Weight Reduction Medicine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Weight Reduction Medicine Market Facts & Figures by Country
- 5.7.1 South America Weight Reduction Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Weight Reduction Medicine Sales by Country (2021-2032)
- 5.7.3 South America Weight Reduction Medicine Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Weight Reduction Medicine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Weight Reduction Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Weight Reduction Medicine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Weight Reduction Medicine Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Weight Reduction Medicine Sales by Type (2021-2032)
- 6.1.1 Global Weight Reduction Medicine Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Weight Reduction Medicine Sales Market Share by Type (2021-2032)
- 6.2 Global Weight Reduction Medicine Revenue by Type (2021-2032)
- 6.2.1 Global Weight Reduction Medicine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Weight Reduction Medicine Revenue Market Share by Type (2021-2032)
- 6.3 Global Weight Reduction Medicine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Weight Reduction Medicine Sales by Application (2021-2032)
- 7.1.1 Global Weight Reduction Medicine Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Weight Reduction Medicine Sales Market Share by Application (2021-2032)
- 7.2 Global Weight Reduction Medicine Revenue by Application (2021-2032)
- 7.2.1 Global Weight Reduction Medicine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Weight Reduction Medicine Revenue Market Share by Application (2021-2032)
- 7.3 Global Weight Reduction Medicine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Weight Reduction Medicine Value Chain Analysis
- 8.1.1 Weight Reduction Medicine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Weight Reduction Medicine Production Mode & Process
- 8.2 Weight Reduction Medicine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Weight Reduction Medicine Distributors
- 8.2.3 Weight Reduction Medicine Customers
9 Global Weight Reduction Medicine Analyzing Market Dynamics
- 9.1 Weight Reduction Medicine Industry Trends
- 9.2 Weight Reduction Medicine Industry Drivers
- 9.3 Weight Reduction Medicine Industry Opportunities and Challenges
- 9.4 Weight Reduction Medicine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst